American Bio Medica Corporation (ABMC)

American Bio Medica Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	0.91	2.22	4.15	3.66	3.87
Revenue Growth (YoY)	-58.84%	-46.52%	13.46%	-5.60%	-21.20%
Cost of Revenue	1.11	1.67	2.91	2.47	2.58
Gross Profit	-0.19	0.55	1.24	1.18	1.29
Selling, General & Admin	1.05	1.64	1.77	1.7	1.96
Research & Development	0.09	0.09	0.09	0.08	0.09
Other Operating Expenses	0.03	0.68	-0.17	-0.09	-0.26
Operating Expenses	1.14	1.73	1.86	1.78	2.05
Operating Income	-1.24	-1.18	-0.62	-0.59	-0.76
Interest Income	0	0.19	0.18	0.27	0
Interest Expense	0.19	0.19	0.18	0.27	0.28
Other Expense / Income	-0.03	-0.72	0.17	0.09	-0.02
Pretax Income	-1.41	-0.46	-0.79	-0.69	-1.03
Income Tax	0	0	0	-0.01	0
Net Income	-1.41	-0.46	-0.8	-0.68	-1.03
Shares Outstanding (Basic)	48	43	36	33	30
Shares Outstanding (Diluted)	48	43	36	33	30
Shares Change	12.29%	20.26%	9.32%	8.01%	3.09%
EPS (Basic)	-0.03	-0.01	-0.02	-0.02	-0.03
EPS (Diluted)	-0.03	-0.01	-0.02	-0.02	-0.03
Free Cash Flow	-0.77	-0.67	-0.49	0.06	-0.24
Free Cash Flow Per Share	-0.02	-0.02	-0.01	0.00	-0.01
Gross Margin	-21.14%	24.71%	29.85%	32.39%	33.26%
Operating Margin	-136.04%	-53.16%	-14.97%	-16.22%	-19.68%
Profit Margin	-154.44%	-20.87%	-19.19%	-18.63%	-26.55%
Free Cash Flow Margin	-84.12%	-30.34%	-11.74%	1.59%	-6.25%
EBITDA	-1.16	-0.43	-0.62	-0.59	-0.76
EBITDA Margin	-127.38%	-19.57%	-14.97%	-16.22%	-19.68%
Depreciation & Amortization	0.05	0.07	0.08	0.08	0.08
EBIT	-1.21	-0.5	-0.7	-0.67	-0.84
EBIT Margin	-132.97%	-22.63%	-16.88%	-18.44%	-21.77%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.